566 related articles for article (PubMed ID: 28189812)
1. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
Yin S; Huai J; Chen X; Yang Y; Zhang X; Gan Y; Wang G; Gu X; Li J
Acta Biomater; 2015 Oct; 26():274-85. PubMed ID: 26300335
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models.
Zhang Y; Zhang H; Wu W; Zhang F; Liu S; Wang R; Sun Y; Tong T; Jing X
Int J Nanomedicine; 2014; 9():2019-30. PubMed ID: 24790440
[TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
Bano S; Afzal M; Waraich MM; Alamgir K; Nazir S
Int J Pharm; 2016 Nov; 513(1-2):554-563. PubMed ID: 27651326
[TBL] [Abstract][Full Text] [Related]
7. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q
J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298
[TBL] [Abstract][Full Text] [Related]
8. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
9. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
Yang Y; Li N; Nie Y; Sheng M; Yue D; Wang G; Tang JZ; Gu Z
J Biomed Nanotechnol; 2015 Sep; 11(9):1628-39. PubMed ID: 26485931
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.
Wang F; Zhang D; Zhang Q; Guo S; Zheng D; Hao L; Guo H; Li C
J Drug Target; 2013 Feb; 21(2):137-45. PubMed ID: 23046502
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
Song RF; Li XJ; Cheng XL; Fu AR; Wang YH; Feng YJ; Xiong Y
Oncol Rep; 2014 Oct; 32(4):1481-8. PubMed ID: 25051142
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.
Vinothini K; Rajendran NK; Ramu A; Elumalai N; Rajan M
Biomed Pharmacother; 2019 Feb; 110():906-917. PubMed ID: 30572195
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
Yin T; Wang L; Yin L; Zhou J; Huo M
Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
Wu J; Tang C; Yin C
Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
[TBL] [Abstract][Full Text] [Related]
16. Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.
Cheng LC; Jiang Y; Xie Y; Qiu LL; Yang Q; Lu HY
Oncotarget; 2017 Jan; 8(2):3315-3326. PubMed ID: 27926514
[TBL] [Abstract][Full Text] [Related]
17. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated pH-Dependent Thermo-Sensitive Copolymer: In Vitro and In Vivo Evaluation.
Zhao H; Tao L; Yu R; Yuan H; Lan M
J Nanosci Nanotechnol; 2015 Aug; 15(8):5553-8. PubMed ID: 26369116
[TBL] [Abstract][Full Text] [Related]
19. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
20. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]